Literature DB >> 956165

Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa.

R Radcliffe, Y Nemerson.   

Abstract

Coagulation Factor VII from bovine plasma is a glycoprotein containing a single peptide chain. The NH2-terminal sequence of Ala-Asx-Gly-Phe-Leu- is homologous with the NH2 termini of prothrombin, Factor IX, and the light chain of Factor X. Factor Xa in the presence of calcium ions and phospholipid cleaves Factor VII at an Arg-Ile bond in the sequence Arg-Ile-Val-Gly-Gly-, producing a two-chain molecule with at least 85 times the coagulant activity of single-chain Factor VII and a new NH2-terminal sequence homologous with the corresponding chains of thrombin, Factor IXa and Factor Xa. A second slower cleavage at an Arg-Gly bond destroys Factor VII activity. Bovine Factor VII, unlike prothrombin, Factor IX, and Factor X, is rapidly inhibited by diisopropylphosphorofluoridate (iPr2PF). [3H]iPr2PF is readily incorporated into one-chain, two-chain, and three-chain forms of Factor VII up to ratios of approximately 0.9 moles of [3H]diisopropylphosphate per mole of protein. The radioactive peptides generated from each form of [32P]iPr2PF-inhibited Factor VII by tryptic and thermolytic digestion were found to migrate together on paper electrophoresis. This indicates that the iPr2PF is incorporated stoichiometrically into the same specific site in each form.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956165

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Manipulation of the membrane binding site of vitamin K-dependent proteins: enhanced biological function of human factor VII.

Authors:  A M Shah; W Kisiel; D C Foster; G L Nelsestuen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

2.  Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region.

Authors:  F Bernardi; P Patracchini; D Gemmati; M Ferrati; P Arcieri; M Papacchini; R Redaelli; F Baudo; G Mariani; G Marchetti
Journal:  Hum Genet       Date:  1993-11       Impact factor: 4.132

Review 3.  Surface-mediated defense reactions. The plasma contact activation system.

Authors:  R W Colman
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

4.  Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition.

Authors:  A L Kuharsky; A L Fogelson
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

5.  Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7).

Authors:  G Marchetti; P Patracchini; D Gemmati; V DeRosa; M Pinotti; G Rodorigo; A Casonato; A Girolami; F Bernardi
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

6.  Expression and purification of recombinant human coagulation factor VII fused to a histidine tag using Gateway technology.

Authors:  Raheleh Halabian; Mahdi Edalati Fathabad; Nasser Masroori; Amaneh Mohammadi Roushandeh; Sasan Saki; Nasser Amirizadeh; Ali Jahanian Najafabadi; Ahmad Gharehbaghian; Mehryar Habibi Roudkenar
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

7.  Binding of human factor VII and VIIa to monocytes.

Authors:  G J Broze
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

8.  Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease.

Authors:  H A Chapman; C L Allen; O L Stone; D S Fair
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

9.  Turnover of factor X and of prothrombin in rabbits fed on a standard or cholesterol-supplemented diet.

Authors:  K A Mitropoulos; M P Esnouf
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

10.  Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).

Authors:  J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.